If the mechanism of action in tumour suppression of anti-PD-1 antibody is established in many types of cancer, it will enable us to provide an explain regarding the higher response rate of anti-PD-1 antibody compared to anti-PD-L1 antibody in clinical practice [10]. Here, CD274 is linked to neoplasm.